It inhibits the activation of transcription factor AP-1 (105), blocks the nuclear translocation of p50/p65 NF-κB proteins and their binding to the COX-2 promoter (106), thereby suppressing the proliferation of human cervical cancer and non-small cell lung cancer cells. This evidence concerns the gene NFKB1 and non-small cell lung carcinoma.